A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China

Thread starter International: Top News And Analysis
Start date May 31, 2026

International: Top News And Analysis

Guest

May 31, 2026

An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial, according to data released Sunday.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China

Prefix: N/A

Forum: World News

Start date: May 31, 2026

Last reply date: May 31, 2026

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, May 31, 2026

Replies: 0

Views: 10

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search